CoChat

Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma

Open access
Eberl, Markus, Mangelberger, Doris, Swanson, Jacob B., Verhaegen, Monique E., Harms, Paul W., Frohm, Marcus L., Dlugosz, Andrzej A., Wong, Sunny Y. · 2018 · Cancer Cell
Cited by 53

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

SUMMARY Hedgehog (Hh) pathway inhibitors such as vismodegib are highly effective for treating basal cell carcinoma (BCC); however, residual tumor cells frequently persist and regenerate the primary tumor upon drug discontinuation. Here, we show that BCCs are organized into 2 molecularly and functionally distinct compartments. Whereas interior Hh+/Notch+ suprabasal cells undergo apoptosis in response to vismodegib, peripheral Hh+++/Notch− basal cells survive throughout treatment. Inhibiting Notch specifically promotes tumor persistence without causing drug resistance, while activating Notch is sufficient to regress already established lesions. Altogether, these findings suggest that the 3-dimensional architecture of BCCs establishes a natural hierarchy of drug response in the tumor, and that this hierarchy can be overcome, for better or worse, by modulating Notch.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2017.12.015

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 53

Metadata

Authors
Eberl, M., Mangelberger, D., Swanson, J. B., Verhaegen, M. E., Harms, P. W., Frohm, M. L., Dlugosz, A. A., & Wong, S. Y.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2018-02
Volume
33
Issue
2
Pages
229-243.e4
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2786577426
Cited by
53
References
4
FWCI
2.04
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.